Literature DB >> 22619278

Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.

Pearl Quijada1, Haruhiro Toko, Kimberlee M Fischer, Brandi Bailey, Patrick Reilly, Kristin D Hunt, Natalie A Gude, Daniele Avitabile, Mark A Sussman.   

Abstract

RATIONALE: Bone marrow-derived cells to treat myocardial injury improve cardiac function and support beneficial cardiac remodeling. However, survival of stem cells is limited due to low proliferation of transferred cells.
OBJECTIVE: To demonstrate long-term potential of c-kit(+) bone marrow stem cells (BMCs) enhanced with Pim-1 kinase to promote positive cardiac remodeling. METHODS AND
RESULTS: Lentiviral modification of c-kit(+) BMCs to express Pim-1 (BMCeP) increases proliferation and expression of prosurvival proteins relative to BMCs expressing green fluorescent protein (BMCe). Intramyocardial delivery of BMCeP at time of infarction supports improvements in anterior wall dimensions and prevents left ventricle dilation compared with hearts treated with vehicle alone. Reduction of the akinetic left ventricular wall was observed in BMCeP-treated hearts at 4 and 12 weeks after infarction. Early recovery of cardiac function in BMCeP-injected hearts facilitated modest improvements in hemodynamic function up to 12 weeks after infarction between cell-treated groups. Persistence of BMCeP is improved relative to BMCe within the infarct together with increased recruitment of endogenous c-kit(+) cells. Delivery of BMC populations promotes cellular hypertrophy in the border and infarcted regions coupled with an upregulation of hypertrophic genes. Thus, BMCeP treatment yields improved structural remodeling of infarcted myocardium compared with control BMCs.
CONCLUSIONS: Genetic modification of BMCs with Pim-1 may serve as a therapeutic approach to promote recovery of myocardial structure. Future approaches may take advantage of salutary BMC actions in conjunction with other stem cell types to increase efficacy of cellular therapy and improve myocardial performance in the injured myocardium.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22619278      PMCID: PMC3398618          DOI: 10.1161/CIRCRESAHA.112.265207

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  61 in total

1.  Lentivirus transduction of bone marrow hemopoietic precursor cells with Lin-c-kit+ phenotype ex vivo using a genetic construct containing green fluorescent protein gene.

Authors:  N V Radyukhina; P N Rutkevich; T I Aref'yeva; T Kh Gurskaya; I N Rybalkin; A Ya Shevelyov; M A Slinkin; T N Vlasik; O P Il'yinskaya; E M Tararak
Journal:  Bull Exp Biol Med       Date:  2007-06       Impact factor: 0.804

2.  Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.

Authors:  Yousuke T Horikawa; Mathivadhani Panneerselvam; Yoshitaka Kawaraguchi; Yasuo M Tsutsumi; Sameh S Ali; Ravi C Balijepalli; Fiona Murray; Brian P Head; Ingrid R Niesman; Timo Rieg; Volker Vallon; Paul A Insel; Hemal H Patel; David M Roth
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

3.  Synergistic effect of adipose-derived stem cell therapy and bone marrow progenitor recruitment in ischemic heart.

Authors:  Masaaki Ii; Miki Horii; Ayumi Yokoyama; Taro Shoji; Yutaka Mifune; Atsuhiko Kawamoto; Michio Asahi; Takayuki Asahara
Journal:  Lab Invest       Date:  2010-12-06       Impact factor: 5.662

4.  Non-hypoxic stabilization of HIF-Iα during coordinated interaction between Akt and angiopoietin-1 enhances endothelial commitment of bone marrow stem cells.

Authors:  Vien Khach Lai; Muhammad Rizwan Afzal; Muhammad Ashraf; Shujia Jiang; Husnain Kh Haider
Journal:  J Mol Med (Berl)       Date:  2012-01-12       Impact factor: 4.599

5.  Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair.

Authors:  Francesco S Loffredo; Matthew L Steinhauser; Joseph Gannon; Richard T Lee
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

6.  Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model.

Authors:  Regina C S Goldenberg; Linda A Jelicks; Fabio S A Fortes; Louis M Weiss; Leonardo L Rocha; Dazhi Zhao; Antonio Campos de Carvalho; David C Spray; Herbert B Tanowitz
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

7.  Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction.

Authors:  Buddhadeb Dawn; Sumit Tiwari; Magdalena J Kucia; Ewa K Zuba-Surma; Yiru Guo; Santosh K Sanganalmath; Ahmed Abdel-Latif; Greg Hunt; Robert J Vincent; Hisham Taher; Nathan J Reed; Mariusz Z Ratajczak; Roberto Bolli
Journal:  Stem Cells       Date:  2008-04-17       Impact factor: 6.277

8.  Bone marrow cells adopt the cardiomyogenic fate in vivo.

Authors:  Marcello Rota; Jan Kajstura; Toru Hosoda; Claudia Bearzi; Serena Vitale; Grazia Esposito; Grazia Iaffaldano; M Elena Padin-Iruegas; Arantxa Gonzalez; Roberto Rizzi; Narissa Small; John Muraski; Roberto Alvarez; Xiongwen Chen; Konrad Urbanek; Roberto Bolli; Steven R Houser; Annarosa Leri; Mark A Sussman; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-26       Impact factor: 11.205

9.  Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload.

Authors:  Jin Endo; Motoaki Sano; Jun Fujita; Kentaro Hayashida; Shinsuke Yuasa; Naoki Aoyama; Yuji Takehara; Osamu Kato; Shinji Makino; Satoshi Ogawa; Keiichi Fukuda
Journal:  Circulation       Date:  2007-08-13       Impact factor: 29.690

10.  Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction.

Authors:  Ewa K Zuba-Surma; Yiru Guo; Hisham Taher; Santosh K Sanganalmath; Greg Hunt; Robert J Vincent; Magda Kucia; Ahmed Abdel-Latif; Xian-Liang Tang; Mariusz Z Ratajczak; Buddhadeb Dawn; Roberto Bolli
Journal:  J Cell Mol Med       Date:  2010-07-12       Impact factor: 5.310

View more
  20 in total

1.  Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms.

Authors:  Jason M Duran; Catherine A Makarewich; Thomas E Sharp; Timothy Starosta; Fang Zhu; Nicholas E Hoffman; Yumi Chiba; Muniswamy Madesh; Remus M Berretta; Hajime Kubo; Steven R Houser
Journal:  Circ Res       Date:  2013-06-25       Impact factor: 17.367

Review 2.  Making it stick: chasing the optimal stem cells for cardiac regeneration.

Authors:  Pearl Quijada; Mark A Sussman
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-11

3.  Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.

Authors:  Mirko Völkers; Mathias H Konstandin; Shirin Doroudgar; Haruhiro Toko; Pearl Quijada; Shabana Din; Anya Joyo; Luis Ornelas; Kaitleen Samse; Donna J Thuerauf; Natalie Gude; Christopher C Glembotski; Mark A Sussman
Journal:  Circulation       Date:  2013-09-05       Impact factor: 29.690

Review 4.  c-kit(+) cells: the tell-tale heart of cardiac regeneration?

Authors:  Patrizia Nigro; Gianluca Lorenzo Perrucci; Aoife Gowran; Marco Zanobini; Maurizio C Capogrossi; Giulio Pompilio
Journal:  Cell Mol Life Sci       Date:  2015-01-10       Impact factor: 9.261

5.  Regulation of cardiac hypertrophic signaling by prolyl isomerase Pin1.

Authors:  Haruhiro Toko; Mathias H Konstandin; Shirin Doroudgar; Lucia Ormachea; Eri Joyo; Anya Y Joyo; Shabana Din; Natalie A Gude; Brett Collins; Mirko Völkers; Donna J Thuerauf; Christopher C Glembotski; Chun-Hau Chen; Kun Ping Lu; Oliver J Müller; Takafumi Uchida; Mark A Sussman
Journal:  Circ Res       Date:  2013-03-13       Impact factor: 17.367

6.  Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.

Authors:  John W Macarthur; Jeffrey E Cohen; Jeremy R McGarvey; Yasuhiro Shudo; Jay B Patel; Alen Trubelja; Alexander S Fairman; Bryan B Edwards; George Hung; William Hiesinger; Andrew B Goldstone; Pavan Atluri; Robert L Wilensky; James J Pilla; Joseph H Gorman; Robert C Gorman; Y Joseph Woo
Journal:  Circ Res       Date:  2013-12-23       Impact factor: 17.367

7.  Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction.

Authors:  Sang-Ging Ong; Bruno C Huber; Won Hee Lee; Kazuki Kodo; Antje D Ebert; Yu Ma; Patricia K Nguyen; Sebastian Diecke; Wen-Yi Chen; Joseph C Wu
Journal:  Circulation       Date:  2015-08-25       Impact factor: 29.690

Review 8.  Cell and gene therapy for severe heart failure patients: the time and place for Pim-1 kinase.

Authors:  Sailay Siddiqi; Mark A Sussman
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-08

9.  Cardiac c-Kit Biology Revealed by Inducible Transgenesis.

Authors:  Natalie A Gude; Fareheh Firouzi; Kathleen M Broughton; Kelli Ilves; Kristine P Nguyen; Christina R Payne; Veronica Sacchi; Megan M Monsanto; Alexandria R Casillas; Farid G Khalafalla; Bingyan J Wang; David E Ebeid; Roberto Alvarez; Walter P Dembitsky; Barbara A Bailey; Jop van Berlo; Mark A Sussman
Journal:  Circ Res       Date:  2018-04-10       Impact factor: 17.367

10.  Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1.

Authors:  Mirko Völkers; Haruhiro Toko; Shirin Doroudgar; Shabana Din; Pearl Quijada; Anya Y Joyo; Luis Ornelas; Eri Joyo; Donna J Thuerauf; Mathias H Konstandin; Natalie Gude; Christopher C Glembotski; Mark A Sussman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.